This article is part of a Special Issue “Neuroendocrine-Immune Axis in Health and Disease.”
During pregnancy, it is evolutionarily advantageous for inflammatory immune responses that …

With evolving diagnostic criteria and the advent of new oral and parenteral therapies for MS,
most current diagnostic and treatment algorithms need revision and updating. The diagnosis …

Background Patients with multiple sclerosis (MS) or Crohn's disease (CD) being treated with
natalizumab (Tysabri®, Biogen) who are planning to become pregnant or discover they are …

During pregnancy, the mother allows the immunologically distinct fetoplacental unit to
develop and grow. Opinions are divided as to whether this represents a state of fetal-specific …

Multiple Sclerosis (MuS) is a disease caused due to an autoimmune attack against myelin
components in which non proteic mediators may play a role. Recent research in …

Autoimmune diseases represent a complex heterogeneous group of disorders that occur as
a results of immune homeostasis dysregulation and loss of self-tolerance. Interestingly, more …

The burden of multiple sclerosis (MS) in women of childbearing potential is increasing, with
peak incidence around the age of 30 years, increasing incidence and prevalence, and …

Background: The incidence of multiple sclerosis (MS) in Denmark has doubled in women
since 1970, whereas it has been almost unchanged in men. Objectives: To investigate …

Therapeutic plasma exchange (TPE) has been demonstrated to be of significant clinical
value in a number of diseases and conditions, with well‐established guidelines and …

When contemplating a pregnancy, women treated for multiple sclerosis (MS) with a disease-
modifying drug must decide to discontinue their medication before conception or risk …